StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
CSTL

Castle Biosciences, Inc.

CSTL Nasdaq Services-Medical Laboratories EDGAR ↗
$30.39
+3.60 +13.44%

Key statistics

from XBRL data in SEC filings
Market cap
$928M
Revenue (TTM)
$357M
Net income (TTM)
-$19.4M
EPS (TTM)
$-0.64
P/E ratio
Dividend yield
Free cash flow
$28.3M
Cash
$62.1M
Total assets
$561M
Gross margin
16.2%
52-week range
$14.59 – $44.28

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-Q Quarter ended 2026-06-30 Jul 30, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jul 30, 2026 8-K Shareholder vote results May 29, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 6, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Feb 26, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2026 10-Q Quarter ended 2025-09-30 Nov 3, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 3, 2025 8-K Amended charter or bylaws Aug 8, 2025 10-Q Quarter ended 2025-06-30 Aug 4, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 4, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Shareholder vote results May 23, 2025 10-Q Quarter ended 2025-03-31 May 5, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 5, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Feb 27, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2025 10-Q Quarter ended 2024-09-30 Nov 4, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 4, 2024 10-Q Quarter ended 2024-06-30 Aug 5, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 5, 2024 8-K Shareholder vote results May 24, 2024 10-Q Quarter ended 2024-03-31 May 2, 2024 8-K Results of operations (earnings release); Regulation FD disclosure May 2, 2024 8-K Entered a material agreement; Director or officer change Mar 27, 2024 10-K Fiscal year ended 2023-12-31 Feb 28, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Feb 28, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Jan 8, 2024 8-K Director or officer change Nov 9, 2023 10-Q Quarter ended 2023-09-30 Nov 2, 2023 8-K Results of operations (earnings release); Regulation FD disclosure Nov 2, 2023 10-Q Quarter ended 2023-06-30 Aug 2, 2023 8-K Results of operations (earnings release); Regulation FD disclosure Aug 2, 2023 8-K Regulation FD disclosure Jun 5, 2023 8-K Shareholder vote results Jun 1, 2023 10-Q Quarter ended 2023-03-31 May 3, 2023 8-K Results of operations (earnings release); Regulation FD disclosure May 3, 2023 10-K Fiscal year ended 2022-12-31 Feb 28, 2023